Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Infect Immun ; 77(6): 2262-71, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19307219

RESUMO

Capnocytophaga canimorsus is a bacterium of the canine oral flora known since 1976 to cause rare but severe septicemia and peripheral gangrene in patients that have been in contact with a dog. It was recently shown that these bacteria do not elicit an inflammatory response (H. Shin, M. Mally, M. Kuhn, C. Paroz, and G. R. Cornelis, J. Infect. Dis. 195:375-386, 2007). Here, we analyze their sensitivity to the innate immune system. Bacteria from the archetype strain Cc5 were highly resistant to killing by complement. There was little membrane attack complex (MAC) deposition in spite of C3b deposition. Cc5 bacteria were as resistant to phagocytosis by human polymorphonuclear leukocytes (PMNs) as Yersinia enterocolitica MRS40, endowed with an antiphagocytic type III secretion system. We isolated Y1C12, a transposon mutant that is hypersensitive to killing by complement via the antibody-dependent classical pathway. The mutation inactivated a putative glycosyltransferase gene, suggesting that the Y1C12 mutant was affected at the level of a capsular polysaccharide or lipopolysaccharide (LPS) structure. Cc5 appeared to have several polysaccharidic structures, one being altered in Y1C12. The structure missing in Y1C12 could be purified by classical LPS purification procedures and labeled by tritiated palmitate, indicating that it is more likely to be an LPS structure than a capsule. Y1C12 bacteria were also more sensitive to phagocytosis by PMNs than wild-type bacteria. In conclusion, a polysaccharide structure, likely an LPS, protects C. canimorsus from deposition of the complement MAC and from efficient phagocytosis by PMNs.


Assuntos
Capnocytophaga/imunologia , Proteínas do Sistema Complemento/imunologia , Viabilidade Microbiana , Neutrófilos/imunologia , Animais , Proteínas de Bactérias/genética , Atividade Bactericida do Sangue , Contagem de Colônia Microbiana , Elementos de DNA Transponíveis , Cães , Glicosiltransferases/genética , Humanos , Lipopolissacarídeos/isolamento & purificação , Lipopolissacarídeos/metabolismo , Dados de Sequência Molecular , Mutagênese Insercional
2.
Sci Rep ; 6: 38914, 2016 12 15.
Artigo em Inglês | MEDLINE | ID: mdl-27974829

RESUMO

Capnocytophaga canimorsus is a dog's and cat's oral commensal which can cause fatal human infections upon bites or scratches. Infections mainly start with flu-like symptoms but can rapidly evolve in fatal septicaemia with a mortality as high as 40%. Here we present the discovery of a polysaccharide capsule (CPS) at the surface of C. canimorsus 5 (Cc5), a strain isolated from a fulminant septicaemia. We provide genetic and chemical data showing that this capsule is related to the lipooligosaccharide (LOS) and probably composed of the same polysaccharide units. A CPS was also found in nine out of nine other strains of C. canimorsus. In addition, the genomes of three of these strains, sequenced previously, contain genes similar to those encoding CPS biosynthesis in Cc5. Thus, the presence of a CPS is likely to be a common property of C. canimorsus. The CPS and not the LOS confers protection against the bactericidal effect of human serum and phagocytosis by macrophages. An antiserum raised against the capsule increased the killing of C. canimorsus by human serum thus showing that anti-capsule antibodies have a protective role. These findings provide a new major element in the understanding of the pathogenesis of C. canimorsus.


Assuntos
Cápsulas Bacterianas/química , Capnocytophaga/química , Lipopolissacarídeos/química , Polissacarídeos Bacterianos/química , Animais , Anticorpos Antibacterianos/imunologia , Cápsulas Bacterianas/imunologia , Capnocytophaga/imunologia , Capnocytophaga/patogenicidade , Gatos , Cães , Infecções por Bactérias Gram-Negativas/imunologia , Humanos , Lipopolissacarídeos/imunologia , Polissacarídeos Bacterianos/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA